Letter to the Editor Open Access
Volume 2 | Issue 1 | DOI: https://doi.org/10.33696/Psychiatry.2.012
The Screen Paradox: Cognitive Costs in the Digital Age
Vipul Janardan1,*, Ravleen Suri2
- 1Senior Resident, Department of Psychiatry, Institute of Human Behaviour and Allied Sciences, New Delhi, India
- 2Junior Resident, Department of Psychiatry, Institute of Human Behaviour and Allied Sciences, New Delhi, India
Corresponding Author
Vipul Janardan, vipuljanardan777@gmail.com
Received Date: May 12, 2024
Accepted Date: July 10, 2024
Janardan V, Suri K. The Screen Paradox: Cognitive Costs in the Digital Age. Arch Psychiatry. 2024;2(1):33-34.
Copyright: © 2024 Janardan V, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Exercise Benefits on Alzheimer’s Disease
Alzheimer’s disease (AD) is an age-related neurodegenerative disorder [1] and the most common cause of human dementia, accounting for approximately 60%?80% of cases. It is estimated that more than 30 million AD patients, and the number likely to increase to over 100 million by 2050 because of the increase of the elderly population [2].
Effect of Exosomes on Alzheimer’s Disease
AD is a neurodegenerative disease characterized by progressive cognitive impairment, behavioral changes, memory loss and executive dysfunction, all of which present serious threats to the health of older people.
Virtual Reality Zoo Therapy: An Interactive Relaxing System for Alzheimer’s Disease
The number of people with Alzheimer’s disease (AD) is on the rise, yet there is no effective pharmacological treatment that can slow or reverse the disease’s progress
Much is Known about Caregiver Burden in Dementia - What is Next? The Role of Comorb idities and Future Perspectives
Care for patients with chronic debilitating neurological diseases is often demanding and can result in a variety of negative consequences including mental and physical morbidity.
Glucose Metabolism is a Better Marker for Predicting Clinical Alzheimer’s Disease than Amyloid or Tau
Alzheimer’s disease (AD) research has long been dominated with communications regarding the amyloid hypothesis and targeting amyloid clearance through pharmacological therapies from the brain [1].